Year Established: 2003
Registration Capital: 2 million baht
Managing Director: Ms. Wanna Sae-Ooy
In DSC set up Hemotrans Co., Ltd., its affiliated Thai company to undertake trials of Dextran-Hemoglobin in Bangkok. Thailand is one of Asia’s leaders in the field of Health Care, with an annual income of one billion dollars (USD) from foreign patients who travel to Thailand specifically for medical treatment. To support this growing Health Care sector, the Thai government has announced several funding programs to attract international biotechnology projects. Moreover, it has adopted a flexible regulatory strategy that is designed to reduce the costs and time